PhALLCON Soars to New Heights-Faster, Stronger, but Better?

JAMA. 2024 Jun 4;331(21):1805-1806. doi: 10.1001/jama.2024.5871.
No abstract available

Publication types

  • Editorial
  • Historical Article
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Humans
  • Imatinib Mesylate / therapeutic use
  • Philadelphia Chromosome
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
  • Randomized Controlled Trials as Topic

Substances

  • ponatinib
  • Imatinib Mesylate
  • Antineoplastic Agents